Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Linde JJ, Kelbæk H, Hansen TF, Sigvardsen PE, Torp-Pedersen C, Bech J, Heitmann M, Nielsen OW, Høfsten D, Kühl JT, Raymond IE, Kristiansen OP, Svendsen IH, Vall-Lamora MHD, Kragelund C, de Knegt M, Hove JD, Jørgensen T, Fornitz GG, Steffensen R, Jurlander B, Abdulla J, Lyngbæk S, Elming H, Therkelsen SK, Jørgensen E, Kløvgaard L, Bang LE, Hansen PR, Helqvist S, Galatius S, Pedersen F, Abildgaard U, Clemmensen P, Saunamäki K, Holmvang L, Engstrøm T, Gislason G, Køber LV, Kofoed KF.

J Am Coll Cardiol. 2020 Feb 11;75(5):453-463. doi: 10.1016/j.jacc.2019.12.012.

PMID:
32029126
2.

Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis.

Teerlink JR, Davison BA, Cotter G, Maggioni AP, Sato N, Chioncel O, Ertl G, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Edwards C, Senger S, Teichman SL, Nielsen OW, Voors AA, Metra M.

Eur J Heart Fail. 2019 Dec 30. doi: 10.1002/ejhf.1692. [Epub ahead of print]

PMID:
31886953
3.

Clinical Applicability of Lung Ultrasound Methods in the Emergency Department to Detect Pulmonary Congestion on Computed Tomography.

Miger KC, Fabricius-Bjerre A, Maschmann CP, Wamberg J, Winkler Wille MM, Abild-Nielsen AG, Pedersen L, Lawaetz Schultz HH, Damm Nybing J, Nielsen OW.

Ultraschall Med. 2019 Nov 28. doi: 10.1055/a-1065-7409. [Epub ahead of print] No abstract available.

PMID:
31779032
4.

Clinical Applicability of Lung Ultrasound Methods in the Emergency Department to Detect Pulmonary Congestion on Computed Tomography.

Miger KC, Fabricius-Bjerre A, Maschmann CP, Wamberg J, Winkler Wille MM, Abild-Nielsen AG, Pedersen L, Lawaetz Schultz HH, Damm Nybing J, Nielsen OW.

Ultraschall Med. 2019 Oct 24. doi: 10.1055/a-1021-1470. [Epub ahead of print] Erratum in: Ultraschall Med. 2019 Nov 28;:.

PMID:
31648347
5.

Increased risk of sudden death in untreated primary carnitine deficiency.

Rasmussen J, Dunø M, Lund AM, Steuerwald U, Hansen SH, Joensen HD, Køber L, Nielsen OW.

J Inherit Metab Dis. 2019 Aug 1. doi: 10.1002/jimd.12158. [Epub ahead of print]

PMID:
31373028
6.

Reproducibility of in-hospital worsening heart failure event adjudication in the RELAX-AHF-EU trial.

Hallén J, Maggioni AP, Lopez-De-Sa E, Turazza FM, Witte K, Erdmann E, Dahlström U, Ertl G, Nielsen OW, Sendon JL, Holbro T, Chen CW, Gimpelewicz C, Cowie MR.

Eur J Heart Fail. 2019 Dec;21(12):1661-1662. doi: 10.1002/ejhf.1574. Epub 2019 Jul 29. No abstract available.

PMID:
31359535
7.

Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.

Anholm C, Kumarathurai P, Pedersen LR, Samkani A, Walzem RL, Nielsen OW, Kristiansen OP, Fenger M, Madsbad S, Sajadieh A, Haugaard SB.

Atherosclerosis. 2019 Sep;288:60-66. doi: 10.1016/j.atherosclerosis.2019.07.007. Epub 2019 Jul 5.

PMID:
31326727
8.

Echocardiographic subtypes of heart failure in consecutive hospitalised patients with dyspnoea.

Nielsen OW, Valeur N, Sajadieh A, Fabricius-Bjerre A, Carlsen CM, Kober L.

Open Heart. 2019 Jun 20;6(1):e000928. doi: 10.1136/openhrt-2018-000928. eCollection 2019.

9.

Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease.

Anholm C, Kumarathurai P, Jürs A, Pedersen LR, Nielsen OW, Kristiansen OP, Fenger M, Holst JJ, Madsbad S, Sajadieh A, Haugaard SB.

Diabetol Metab Syndr. 2019 May 31;11:42. doi: 10.1186/s13098-019-0438-6. eCollection 2019.

10.

Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.

Anholm C, Kumarathurai P, Samkani A, Pedersen LR, Boston RC, Nielsen OW, Kristiansen OP, Fenger M, Madsbad S, Sajadieh A, Haugaard SB.

Diabetes Obes Metab. 2019 Aug;21(8):2012-2016. doi: 10.1111/dom.13761. Epub 2019 May 29.

PMID:
31050161
11.

Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU.

Maggioni AP, López-Sendón J, Nielsen OW, Hallén J, Aalamian-Mattheis M, Wang Y, Ertl G.

Eur J Heart Fail. 2019 Mar;21(3):322-333. doi: 10.1002/ejhf.1368. Epub 2019 Jan 2. Erratum in: Eur J Heart Fail. 2020 Jan;22(1):170.

PMID:
30604559
12.

Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial.

Düngen HD, Kober L, Nodari S, Schou M, Otto C, Becka M, Kanefendt F, Winkelmann BR, Gislason G, Richard F, Nielsen OW, Gheorghiade M, Senni M.

Clin Pharmacol Drug Dev. 2019 Oct;8(7):942-951. doi: 10.1002/cpdd.633. Epub 2018 Nov 19.

PMID:
30452784
13.

Sleep Apnea, the Risk of Developing Heart Failure, and Potential Benefits of Continuous Positive Airway Pressure (CPAP) Therapy.

Holt A, Bjerre J, Zareini B, Koch H, Tønnesen P, Gislason GH, Nielsen OW, Schou M, Lamberts M.

J Am Heart Assoc. 2018 Jun 22;7(13). pii: e008684. doi: 10.1161/JAHA.118.008684.

14.

The Reply.

Mattsson N, Nielsen OW, Johnson L, Prescott E, Schnohr P, Jensen GB, Køber L, Sajadieh A.

Am J Med. 2018 Apr;131(4):e169. doi: 10.1016/j.amjmed.2017.11.038. No abstract available.

PMID:
29555046
15.

Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study.

Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A.

Stem Cells Int. 2017;2017:8506370. doi: 10.1155/2017/8506370. Epub 2017 Sep 19.

16.

Prognostic Impact of Mild Hypokalemia in Terms of Death and Stroke in the General Population-A Prospective Population Study.

Mattsson N, Nielsen OW, Johnson L, Prescott E, Schnohr P, Jensen GB, Køber L, Sajadieh A.

Am J Med. 2018 Mar;131(3):318.e9-318.e19. doi: 10.1016/j.amjmed.2017.09.026. Epub 2017 Oct 9.

PMID:
29024624
17.

Mild Hypokalemia and Supraventricular Ectopy Increases the Risk of Stroke in Community-Dwelling Subjects.

Mattsson N, Kumarathurai P, Larsen BS, Nielsen OW, Sajadieh A.

Stroke. 2017 Mar;48(3):537-543. doi: 10.1161/STROKEAHA.116.015439. Epub 2017 Feb 7.

PMID:
28174323
18.

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.

Kumarathurai P, Anholm C, Fabricius-Bjerre A, Nielsen OW, Kristiansen O, Madsbad S, Haugaard SB, Sajadieh A.

J Hypertens. 2017 May;35(5):1070-1078. doi: 10.1097/HJH.0000000000001275.

PMID:
28129251
19.

Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.

Anholm C, Kumarathurai P, Pedersen LR, Nielsen OW, Kristiansen OP, Fenger M, Madsbad S, Sajadieh A, Haugaard SB.

Diabetes Obes Metab. 2017 Jun;19(6):850-857. doi: 10.1111/dom.12891. Epub 2017 Feb 23.

PMID:
28124822
20.

Evaluation of Commercial Self-Monitoring Devices for Clinical Purposes: Results from the Future Patient Trial, Phase I.

Leth S, Hansen J, Nielsen OW, Dinesen B.

Sensors (Basel). 2017 Jan 22;17(1). pii: E211. doi: 10.3390/s17010211.

21.

Data on the quantitative assessment pulmonary ground-glass opacification from coronary computed tomography angiography datasets.

Kühl JT, Kristensen TS, Thomsen AF, Hindsø L, Hansen KL, Nielsen OW, Kelbæk H, Kofoed KF.

Data Brief. 2016 Nov 5;10:6-10. eCollection 2017 Feb.

22.

Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.

Kumarathurai P, Anholm C, Larsen BS, Olsen RH, Madsbad S, Kristiansen O, Nielsen OW, Haugaard SB, Sajadieh A.

Diabetes Care. 2017 Jan;40(1):117-124. doi: 10.2337/dc16-1580. Epub 2016 Oct 19.

PMID:
27797930
23.

Clinical and prognostic correlates of pulmonary congestion in coronary computed tomography angiography data sets.

Kühl JT, Kristensen TS, Thomsen AF, Hindsø L, Hansen KL, Nielsen OW, Kelbæk H, Kofoed KF.

J Cardiovasc Comput Tomogr. 2016 Nov - Dec;10(6):466-472. doi: 10.1016/j.jcct.2016.09.002. Epub 2016 Sep 15.

PMID:
27717753
24.

Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).

Nielsen OW, Sajadieh A, Sabbah M, Greve AM, Olsen MH, Boman K, Nienaber CA, Kesäniemi YA, Pedersen TR, Willenheimer R, Wachtell K.

Circulation. 2016 Aug 9;134(6):455-68. doi: 10.1161/CIRCULATIONAHA.115.021213. Epub 2016 Aug 2.

PMID:
27486164
25.

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study.

Kumarathurai P, Anholm C, Nielsen OW, Kristiansen OP, Mølvig J, Madsbad S, Haugaard SB, Sajadieh A.

Cardiovasc Diabetol. 2016 Jul 26;15(1):105. doi: 10.1186/s12933-016-0425-2.

26.

Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.

Kumarathurai P, Mouridsen MR, Mattsson N, Larsen BS, Nielsen OW, Gerds TA, Sajadieh A.

Europace. 2017 Mar 1;19(3):364-370. doi: 10.1093/europace/euw017.

PMID:
27194537
27.

Long-term prognostic significance of homocysteine in middle-aged and elderly.

Petersen JF, Larsen BS, Sabbah M, Nielsen OW, Kumarathurai P, Sajadieh A.

Biomarkers. 2016 Sep;21(6):490-6. doi: 10.3109/1354750X.2016.1160288. Epub 2016 Mar 24.

PMID:
27008914
28.

Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis.

Blyme A, Asferg C, Nielsen OW, Boman K, Gohlke-Bärwolf C, Wachtell K, Olsen MH.

Scand Cardiovasc J. 2016 Jun;50(3):138-45. doi: 10.3109/14017431.2016.1151928. Epub 2016 Mar 8.

PMID:
26911132
29.

The circadian variation of premature atrial contractions.

Larsen BS, Kumarathurai P, Nielsen OW, Sajadieh A.

Europace. 2016 Oct;18(10):1573-1580. Epub 2015 Dec 24.

PMID:
26705556
30.

Ambulatory cardiac arrhythmias in relation to mild hypokalaemia and prognosis in community dwelling middle-aged and elderly subjects.

Mattsson N, Sadjadieh G, Kumarathurai P, Nielsen OW, Køber L, Sajadieh A.

Europace. 2016 Apr;18(4):585-91. doi: 10.1093/europace/euv204. Epub 2015 Aug 19.

PMID:
26293625
31.

Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation.

Larsen BS, Kumarathurai P, Falkenberg J, Nielsen OW, Sajadieh A.

J Am Coll Cardiol. 2015 Jul 21;66(3):232-241. doi: 10.1016/j.jacc.2015.05.018.

32.

High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy.

Blyme A, Asferg C, Nielsen OW, Sehestedt T, Kesäniemi YA, Gohlke-Bärwolf C, Boman K, Willenheimer R, Ray S, Nienaber CA, Rossebø A, Wachtell K, Olsen MH.

Open Heart. 2015 Feb 4;2(1):e000152. doi: 10.1136/openhrt-2014-000152. eCollection 2015.

33.

Carnitine levels in skeletal muscle, blood, and urine in patients with primary carnitine deficiency during intermission of L-carnitine supplementation.

Rasmussen J, Thomsen JA, Olesen JH, Lund TM, Mohr M, Clementsen J, Nielsen OW, Lund AM.

JIMD Rep. 2015;20:103-11. doi: 10.1007/8904_2014_398. Epub 2015 Feb 10.

34.

Troponin T and N-terminal pro B-Type natriuretic peptide and presence of coronary artery disease.

Mouridsen MR, Sajadieh A, Carlsen CM, Mattsson N, Heitmann M, Nielsen OW.

Scand J Clin Lab Invest. 2015 May;75(3):204-12. doi: 10.3109/00365513.2014.993694. Epub 2015 Jan 28.

PMID:
25629204
35.

Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.

Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K.

Int J Cardiol. 2015 Feb 1;180:122-8. doi: 10.1016/j.ijcard.2014.11.181. Epub 2014 Nov 26.

PMID:
25438232
36.

Hyponatraemia at hospital admission is a predictor of overall mortality.

Balling L, Gustafsson F, Goetze JP, Dalsgaard M, Nielsen H, Boesgaard S, Bay M, Kirk V, Nielsen OW, Køber L, Iversen K.

Intern Med J. 2015 Feb;45(2):195-202. doi: 10.1111/imj.12623.

PMID:
25370908
37.

Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults.

Lamberts M, Nielsen OW, Lip GY, Ruwald MH, Christiansen CB, Kristensen SL, Torp-Pedersen C, Hansen ML, Gislason GH.

J Intern Med. 2014 Dec;276(6):659-66. doi: 10.1111/joim.12302. Epub 2014 Sep 17.

38.

Pentraxin-3 level at admission is a strong predictor of short-term mortality in a community-based hospital setting.

Bastrup-Birk S, Munthe-Fog L, Skjoedt MO, Ma YJ, Nielsen H, Køber L, Nielsen OW, Iversen K, Garred P.

J Intern Med. 2015 May;277(5):562-72. doi: 10.1111/joim.12294. Epub 2014 Sep 8.

39.

Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.

Anholm C, Kumarathurai P, Klit MS, Kristiansen OP, Nielsen OW, Ladelund S, Madsbad S, Sajadieh A, Haugaard SB; AddHope2 Trial Study Group.

BMJ Open. 2014 Jul 16;4(7):e005942. doi: 10.1136/bmjopen-2014-005942.

40.

Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study).

Kruger R, Rasmussen LM, Argraves WS, Eugen-Olsen J, Nielsen OW, Blyme A, Willenheimer R, Wachtell K, Olsen MH.

PLoS One. 2014 Jul 11;9(7):e101522. doi: 10.1371/journal.pone.0101522. eCollection 2014.

41.

Risk stratification in emergency patients by copeptin.

Iversen K, Gøtze JP, Dalsgaard M, Nielsen H, Boesgaard S, Bay M, Kirk V, Nielsen OW, Køber L.

BMC Med. 2014 May 16;12:80. doi: 10.1186/1741-7015-12-80.

42.

Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency.

Rasmussen J, Lund AM, Risom L, Wibrand F, Gislason H, Nielsen OW, Køber L, Duno M.

Mol Genet Metab Rep. 2014 May 22;1:241-248. eCollection 2014.

43.

High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery disease.

Mouridsen MR, Nielsen OW, Carlsen CM, Mattsson N, Ruwald MH, Binici Z, Sajadieh A.

J Inflamm Res. 2014 Mar 21;7:45-55. doi: 10.2147/JIR.S54360. eCollection 2014.

44.

Heart failure association of the European society of cardiology specialist heart failure curriculum.

McDonagh TA, Gardner RS, Lainscak M, Nielsen OW, Parissis J, Filippatos G, Anker SD.

Eur J Heart Fail. 2014 Feb;16(2):151-62. doi: 10.1002/ejhf.41. Epub 2014 Jan 8.

45.

ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study.

Lauridsen BK, Iversen K, Hunter I, Bay M, Kirk V, Nielsen OW, Nielsen H, Boesgaard S, Køber L, Goetze JP.

BMJ Open. 2013 Nov 25;3(11):e003288. doi: 10.1136/bmjopen-2013-003288.

46.

Diagnostic value of exercise-induced changes in circulating high sensitive troponin T in stable chest pain patients.

Mouridsen MR, Nielsen OW, Pedersen OD, Carlsen CM, Intzilakis T, Binici Z, Sajadieh A.

Biomarkers. 2013 Dec;18(8):726-33. doi: 10.3109/1354750X.2013.854835. Epub 2013 Nov 5.

PMID:
24188347
47.

Aortic valve area assessed with 320-detector computed tomography: comparison with transthoracic echocardiography.

Larsen LH, Kofoed KF, Carstensen HG, Mejdahl MR, Andersen MJ, Kjaergaard J, Nielsen OW, Køber L, Møgelvang R, Hassager C.

Int J Cardiovasc Imaging. 2014 Jan;30(1):165-73. doi: 10.1007/s10554-013-0295-6. Epub 2013 Oct 15.

PMID:
24126620
48.

Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening.

Rasmussen J, Køber L, Lund AM, Nielsen OW.

J Inherit Metab Dis. 2014 Mar;37(2):223-30. doi: 10.1007/s10545-013-9640-0. Epub 2013 Aug 21.

PMID:
23963628
49.

Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands.

Rasmussen J, Nielsen OW, Janzen N, Duno M, Gislason H, Køber L, Steuerwald U, Lund AM.

J Inherit Metab Dis. 2014 Mar;37(2):215-22. doi: 10.1007/s10545-013-9606-2. Epub 2013 May 8. Erratum in: J Inherit Metab Dis. 2014 Jul;37(4):657. Gislason, Hannes [added].

PMID:
23653224
50.

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L; Heart Failure Association of the European Society of Cardiology (HFA).

Eur J Heart Fail. 2013 Jul;15(7):808-17. doi: 10.1093/eurjhf/hft050. Epub 2013 Mar 28.

Supplemental Content

Loading ...
Support Center